Adverum Biotechnologies Inc
NASDAQ:ADVM

Watchlist Manager
Adverum Biotechnologies Inc Logo
Adverum Biotechnologies Inc
NASDAQ:ADVM
Watchlist
Price: 4.36 USD Market Closed
Market Cap: 96.3m USD

Wall Street
Price Targets

ADVM Price Targets Summary
Adverum Biotechnologies Inc

Wall Street analysts forecast ADVM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADVM is 5 USD with a low forecast of 4.04 USD and a high forecast of 5.78 USD.

Lowest
Price Target
4.04 USD
7% Downside
Average
Price Target
5 USD
15% Upside
Highest
Price Target
5.78 USD
32% Upside
Adverum Biotechnologies Inc Competitors:
Price Targets
MSB
Mesoblast Ltd
26% Upside
CUV
Clinuvel Pharmaceuticals Ltd
104% Upside
GLTO
Galecto Inc
9% Upside
603087
Gan & Lee Pharmaceuticals
2% Downside
IPH
Innate Pharma SA
210% Upside
SLS
Sellas Life Sciences Group Inc
217% Upside
ACLX
Arcellx Inc
72% Upside
RLYB
Rallybio Corp
33% Upside

Revenue
Forecast

Revenue Estimate
Adverum Biotechnologies Inc

For the last 11 years the compound annual growth rate for Adverum Biotechnologies Inc's revenue is 7%.

7%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Adverum Biotechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Adverum Biotechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADVM's stock price target?
Price Target
5 USD

According to Wall Street analysts, the average 1-year price target for ADVM is 5 USD with a low forecast of 4.04 USD and a high forecast of 5.78 USD.

Back to Top